Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis

The Lancet

Volumn 383, Issue 9922, 2014, Pages 1059-1066

  Yates, Thomas ^a,b,k   Haffner, Steven M ^c   Schulte, Phillip J ^d   Thomas, Laine ^d   Huffman, Kim M ^d   Bales, Connie W ^d,e   Califf, Robert M ^d   Holman, Rury R ^f   McMurray, John J V ^g   Bethel, M Angelyn ^f   Tuomilehto, Jaakko ^h,i,j   Davies, Melanie J ^a,b   Kraus, William E ^d  

^a Lifestyle and Physical Activity Biomedical Research Unit Leicester Loughborough NIHR Diet   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c Duke University School of Medicine ^*

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e DURHAM VA MEDICAL CENTER   (United States)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF GLASGOW   (United Kingdom)

^h DANUBE UNIVERSITY KREMS   (Austria)

ⁱ SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

^j KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^k LEICESTER GENERAL HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NATEGLINIDE; VALSARTAN; PLACEBO;

ADULT; ARTICLE; BEHAVIOR CHANGE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFOUNDING VARIABLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; EUROPE; FEMALE; FOLLOW UP; FUNDING; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NORTH AMERICA; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PEDOMETER; PRIORITY JOURNAL; PROPHYLAXIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SMOKING; UNSTABLE ANGINA PECTORIS; AGED; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; HEART INFARCTION; LIFESTYLE; MOBILIZATION; MULTICENTER STUDY (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC);

AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; GLUCOSE INTOLERANCE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTOR ACTIVITY; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; WALKING;

EID: 84896490531     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)62061-9     Document Type: Article

References (30)

1. Tuomilehto J, Lindström J, Eriksson JG, et al, and the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50
2. Knowler WC, Barrett-Connor E, Fowler SE, et al, and the Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 2002; 346: 393-403
3. Gillies CL, Lambert PC, Abrams KR, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 2008; 336: 1180-85
4. Herman WH, Hoerger TJ, Brandle M, et al, and the Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modifi cation or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 2005; 142: 323-32
5. Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood) 2012; 31: 67-75
6. Schwarz PE, Greaves CJ, Lindström J, Yates T, Davies MJ Nonpharmacological interventions for the prevention of type 2 diabetes mellitus. Nat Rev Endocrinol 2012; 8: 363-73
7. van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil 2010; 17 (suppl 1): S3-8
8. Li J, Siegrist J. Physical activity and risk of cardiovascular disease-a meta-analysis of prospective cohort studies Int J Environ Res Public Health 2012; 9: 391-407
9. Woodcock J, Franco OH, Orsini N, Roberts I. Non-vigorous physical activity and all-cause mortality: systematic review and meta-analysis of cohort studies. Int J Epidemiol 2011; 40: 121-38
10. Samitz G, Egger M, Zwahlen M. Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. Int J Epidemiol 2011; 40: 1382-400
11. Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 2009; 301: 2024-35
12. Shephard RJ. Limits to the measurement of habitual physical activity by questionnaires. Br J Sports Med 2003; 37: 197-206
13. Laukkanen JA, Laaksonen D, Lakka TA, et al. Determinants of cardiorespiratory fitness in men aged 42 to 60 years with and without cardiovascular disease. Am J Cardiol 2009; 103: 1598-604
14. Califf RM, Boolell M, Haffner SM, et al, and the NAVIGATOR Study Group. Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial. Am Heart J 2008; 156: 623-32
15. Holman RR, Haffner SM, McMurray JJ, et al, and the NAVIGATOR Study Group. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med 2010; 362: 1463-76
16. McMurray JJ, Holman RR, Haffner SM, et al, and the NAVIGATOR Study Group. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010; 362: 1477-90
17. Preiss D, Thomas LE, Sun JL, et al. Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial. BMJ Open 2012; 30: e001925
18. Tudor-Locke C, Bassett DR Jr. How many steps/day are enough? Preliminary pedometer indices for public health. Sports Med 2004; 34: 1-8
19. Crespo CJ, Keteyian SJ, Heath GW, Sempos CT. Leisure-time physical activity among US adults. Results from the Third National Health and Nutrition Examination Survey. Arch Intern Med 1996; 156: 93-98
20. NHS Information Centre. Health survey for England-2008: physical activity and fitness. http://www.hscic.gov.uk/catalogue/ PUB00430 (accessed Nov 20, 2013)
21. Laaksonen DE, Lindström J, Lakka TA, et al, and the Finnish diabetes prevention study. Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study Diabetes 2005; 54: 158-65
22. Yates T, Davies M, Gorely T, Bull F, Khunti K. Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance: a randomized controlled trial. Diabetes Care 2009; 32: 1404-10
23. Bravata DM, Smith-Spangler C, Sundaram V, et al. Using pedometers to increase physical activity and improve health: a systematic review. JAMA 2007; 298: 2296-304
24. Helmerhorst HJ, Wijndaele K, Brage S, Wareham NJ, Ekelund U Objectively measured sedentary time may predict insulin resistance independent of moderate- and vigorous-intensity physical activity Diabetes 2009; 58: 1776-79
25. Ekelund U, Franks PW, Sharp S, Brage S, Wareham NJ. Increase in physical activity energy expenditure is associated with reduced metabolic risk independent of change in fatness and fitness Diabetes Care 2007; 30: 2101-06
26. Dwyer T, Ponsonby AL, Ukoumunne OC, et al. Association of change in daily step count over five years with insulin sensitivity and adiposity: population based cohort study. BMJ 2011; 342: c7249
27. Fretts AM, Howard BV, McKnight B, et al. Modest levels of physical activity are associated with a lower incidence of diabetes in a population with a high rate of obesity: the strong heart family study Diabetes Care 2012; 35: 1743-45
28. Laukkanen JA, Rauramaa R, Salonen JT, Kurl S. The predictive value of cardiorespiratory fitness combined with coronary risk evaluation and the risk of cardiovascular and all-cause death J Intern Med 2007; 262: 263-72
29. Stevens J, Cai J, Evenson KR, Thomas R. Fitness and fatness as predictors of mortality from all causes and from cardiovascular disease in men and women in the lipid research clinics study Am J Epidemiol 2002; 156: 832-41
30. Ahmed HM, Blaha MJ, Nasir K, Rivera JJ, Blumenthal RS. Effects of physical activity on cardiovascular disease. Am J Cardiol 2012; 109: 288-95